FILE PHOTO: Workers transfer a container carrying the first batch of Pfizer-BioNTech COVID-19 vaccines at the MASkargo Complex in Sepang, Malaysia February 21, 2021. Malaysia Information Department/Famer Roheni/Handout via REUTERSKUALA LUMPUR: Malaysia will buy additional doses of Pfizer-BioNTech's COVID-19 vaccine, bringing the total secured to 32 million, enough to cover half of its population, the country's science minister Khairy Jamaluddin said on Monday .
The Southeast Asian country last month embarked on a nationwide vaccination programme, targeting to inoculate 80 per cent of its 32 million people by February 2022."All of the Pfizer vaccines secured so far are expected to be delivered by this year," Khairy said at a virtual news conference.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
EU agrees to potentially buy 1.8 billion doses of Pfizer-BioNTech jabBRUSSELS: The European Union cemented its support for Pfizer-BioNTech and its novel COVID-19 vaccine technology on Saturday (May 8) by agreeing to ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Pfizer, BioNTech can raise capacity to 3 billion COVID-19 vaccine doses next year: ReportBioNTech SE could have capacity to make 3 billion doses of the COVID-19 vaccine it developed with partner Pfizer Inc next year, Bloomberg News ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Pfizer/BioNTech COVID-19 shot 91% effective in updated data, protective against South African variantPfizer Inc and BioNTech said on Thursday their vaccine is around 91% effective at preventing COVID-19, citing updated trial data that included participants inoculated for up to six months. The shot also showed early signs of preventing disease in a small subset of study volunteers in South Africa, where a concerning new variant called B.1.351 is circulating. Although lower than the stunning 95% efficacy result reported from its 44,000-person clinical trial in November, overall efficacy of 91.3% shows the vaccine to be a powerful tool against an evolving virus.
Source: YahooSG - 🏆 3. / 71 Read more »
BioNTech-Pfizer say COVID-19 vaccine 100% effective on 12-15 year oldsBERLIN: BioNTech-Pfizer said Wednesday (Mar 31) their vaccine showed 100 per cent efficacy against the coronavirus in 12 to 15 year olds, as they ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
BioNTech-Pfizer say COVID-19 vaccine 100% effective on 12- to 15-year-oldsBERLIN: BioNTech-Pfizer said Wednesday (Mar 31) their vaccine showed 100 per cent efficacy against the coronavirus in 12- to 15-year-olds, as they ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »